Royal Bank of Canada’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Royal Bank of Canada’s Portfolio ENTL Stock Details ENTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-950	Closed	-$23K	–	7210
2017 Q4	$23K	Sell	950 -384	-29%	-$7.38K	﹤0.01%	5557
2017 Q3	$25K	Buy	1,334 +634	+91%	+$11K	﹤0.01%	5850
2017 Q2	$12K	Sell	700 -786	-53%	-$10.9K	﹤0.01%	5750
2017 Q1	$21K	Buy	1,486 +430	+41%	+$6.9K	﹤0.01%	5609
2016 Q4	$20K	Buy	1,056 +356	+51%	+$6.83K	﹤0.01%	5786
2016 Q3	$16K	Hold	700	–	–	﹤0.01%	5635
2016 Q2	$13K	Hold	700	–	–	﹤0.01%	5672
2016 Q1	$13K	Sell	700 -250	-26%	-$4.04K	﹤0.01%	5656
2015 Q4	$16K	Buy	950 +14	+1%	+$238	﹤0.01%	5818
2015 Q3	$17K	Buy	936 +348	+59%	+$7.75K	﹤0.01%	5645
2015 Q2	$15K	Buy	588 +488	+488%	+$12.3K	﹤0.01%	5875
2015 Q1	$2K	Buy	+100	New	+$2.16K	﹤0.01%	5929

Royal Bank of Canada's ENTL Position: Q1 2018 in Review

Royal Bank of Canada sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 950 shares — an estimated $23K sold.

Royal Bank of Canada first reported a position in ENTL in Q1 2015 and held it in 12 quarters. The position peaked at $25K in Q3 2017. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.

Royal Bank of Canada reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Royal Bank of Canada sold 950 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $23K.
Royal Bank of Canada first reported a position in Entellus Medical, Inc. Common Stock in Q1 2015 and held it in 12 quarters.
Royal Bank of Canada's Entellus Medical, Inc. Common Stock position peaked at $25K in Q3 2017.
0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.

Based on Royal Bank of Canada's 13F filing for Q1 2018, filed 15 May 2018.